Searchable abstracts of presentations at key conferences in endocrinology

ea0032p448 | Diabetes | ECE2013

Characteristics of the patients treated at the onset of type 2 diabetes mellitus in our Diabetes Day Hospital (DDH) during 2010–2011

Portillo Cristobal Morales , Pena Ignacio Fernandez , Herrero Cristina Hernandez , Garcia Clara Garcia , Rodriguez Jose Perez , Jimenez Virginia Hernando , Zelaya Raquel Venegas , Olmedo Isabel Serrano , Perez Angel Sendon

Objective: To analyze the demographic and clinical characteristics of the patients treated at the onset of type two diabetes mellitus in our DDH.Material and method: During 2010–2011 were analyzed 171 patients treated in our DDH, studying the following variables: sex, age, BMI, waist circumference, family diabetes history, microvascular and macrovascular long-term complications, smoking habit, rate of associated hypertension (de novo/ previ...

ea0032p483 | Diabetes | ECE2013

Degree of glycemic control in treated type 2 diabetic patients who live in a district of Madrid, Spain

Canizo-Gomez Francisco Javier del , Silveira-Rodriguez Manuela Belen , Perez-Jauregui Carlos de Gorospe , Moreno-Ruiz Inmaculada , Gonzalez-Losada Tomas , Segura-Galindo Amparo

There is a direct relation between the degree of glycemic control and the incidence and progression of diabetic complications. In addition improving glycemic control improves diabetic complications.Aim: To assess the degree of glycemic control, according to published guidelines, in treated type 2 diabetes mellitus patients who live in a district of Madrid, Spain.Methods: Cross-sectional study in 501 consecutive patients with T2DM w...

ea0032p491 | Diabetes | ECE2013

Advantages of using DPP-4 inhibitors in patients with type 2 diabetes mellitus and overweight

Rodriguez Jose Perez , Portillo Cristobal Morales , Pena Ignacio Fernandez , Olmedo Isabel Serrano , Mayor Maria del Carmen De la Cuesta , Perez Angel Sendon

Objective: Analyze the use of DPP-4 inhibitors (iDPP4) in a specialized consultation as well as metabolic impact, weight and safety in patients with diabetes mellitus type 2 (DM2).Material and methods: We analyzed 100 patients with DM2, derivative to Diabetes hospital with debut or poor glycemic control. We initiated them sitagliptin 100 mg/day and reinforced Diabetes education. We studied the HbA1c, weight and severe hypoglycemia. Statistical analysis w...

ea0032p651 | Male reproduction | ECE2013

Sexual dysfunction in cirrhotic patients awaiting liver transplantation

Prol Agustin Ramos , Medina Beatriz Rodriguez , Berenguer Haym Marina , Leon de Zayas Beatriz , Almanza Matilde Rubio , Campos Alborg Vicente , Torres Juan Francisco Merino

Introduction: Data on sexual dysfunction (SD) in cirrhotic patients are limited. Sexual function is a complex area of human behavior with great impact on quality-of-life (QOL). Despite its relevance, it is rarely evaluated in clinical practice in cirrhotic patients. Indeed, published studies are heterogeneous, differ in the way sexual function is assessed, and usually evaluate only one specific aspect of sexual life. Our aim was to evaluate in detail the sexual function of pat...

ea0032p722 | Nuclear receptors and signal transduction | ECE2013

The thyroid hormone receptors inhibit invasive and fibrotic responses to TGFβ by transcriptional cross-talk with smad-transcription factors

Alonso-Merino Elvira , Martin-Orozco Rosa M , Ruiz-Llorente Lidia , Fanjul-Rodriguez Luisa Fernanda , Martinez-Igesias Olaia , Velasco-Martin Juan Pedro , Regadera Javier , Aranda Ana

Transforming growth factor β (TGFβ) signals through activation of Smad transcription factors, which bind to Smad binding elements (SBEs) in target genes. TGFβ can promote cancer cell proliferation and invasion, and plays a key role in the pathogenesis of scleroderma and other fibrotic disorders. We have previously shown that the thyroid hormone receptors (TRs) can block tumor growth and invasion. We now have analyzed the possibility that TRs could antagonize TGF...

ea0032p934 | Pituitary – Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>) | ECE2013

Predictors of hormonal status after pituitary surgery

Taibo Rocio Villar , Casariego Alfonso Vidal , Pomar Maria D Ballesteros , Martin Rosa Alvarez San , Fernandez Javier Fernandez , Arino Teresa Ribas , Risueno Elena Galan , Rodriguez Isidoro Cano

Introduction: Generously supported by IPSEN)-->Surgical treatment of pituitary adenomas (PA) may affect hormone situation.Objective: To evaluate the frequency of hypopituitarism and investigate the potential predictors of worsening or improving pituitary function after PA surgery.Methods: Retrospective analysis of all PA operated in our hospital between 2001 and 2010.<p class="abstext...

ea0032p1111 | Thyroid cancer | ECE2013

Thyroglobulin as an early marker of persistent/recurrent disease in patients with differentiated thyroid carcinoma (DTC)

Aulinas Anna Maso , Colom Cristina Comi , Mendoza Lilian Mathison , Alcantara Valeria Aragon , Mato Eugenia Matute , Corcoy Rosa Pla , Gich Ignasi Saladich , Rodriguez Jose Espinosa , Gonzalez Cintia Blanco

Introduction: Several clinical and molecular markers can be used to establish risk at the time of diagnosis in DTC. Thyroglobulin (Tg), which is essential in follow up, could be an early marker to identify risk patients. Around 25% of patients require 18 months or longer to have indetectable Tg. The presence of Tg antibodies (TgAb) invalidate the follow up of DTC via Tg and this is usually associated with a poor prognosis.Aim: To evaluate the role of Tg ...

ea0029p318 | Cardiovascular Endocrinology and Lipid Metabolism | ICEECE2012

Plasma total homocysteine levels in transsexuals after cross-sex hormonal treatment

Becerra A. , Perez-Lopez G. , Menacho M. , Villar R. , Del Rey J. , Lucio M. , Asenjo N. , Rodriguez-Molina J. , Llopis J. , Aguilar V.

Introduction: The transsexuals are persons that having born with a biological sex feel to belong to the opposite sex. To obtain the sexual characters opposite to his (her) biological sex they need treatment with cross-sex hormones.This treatment with sexual steroids can produce changes in cardiovascular risk factors (CRF). There has been described that hyperhomocysteinemia is an independent CRF that is modifiable by cross-sex hormonal treatment (CHT) in ...

ea0029p357 | Clinical case reports - Pituitary/Adrenal | ICEECE2012

Germ cell tumor of the pituitary–hypothalamic region: case series and clinical experience in the Hospital Universitario Virgen del Rocío

Tous Romero M. , Venegas E. , Soto Moreno A. , Dios Fuentes E. , Garcia Garcia E. , Oliva Rodriguez R. , Garcia Hernandez N. , Leal Cerro A.

Background: Germ cell tumors (germinoma, teratoma, embryonal carcinoma, yolk sac tumor and choriocarcinoma) constitute 0.3–3.4% of all primary intracraneal tumors. Germinoma is the most common and of better prognosis.Aim: Describing the behaviour of germ cell tumors of the pituitary–hypothalamic region: location, clinical characteristics, diagnosis and follow-up.Material and methods: Review of medical records of patients ...

ea0029p692 | Diabetes | ICEECE2012

Therapy with analogous of glp 1 and basal insulin in patients with diabetes mellitus type 2. Our experience.

Perez Rodriguez J. , Morales Portillo C. , Garcia Garcia C. , Fernandez Pena I. , Hernando Jimenez V. , Serrano Olmedo I. , De la Cuesta Mayor C. , Sendon Perez

Objectives: Evaluate the impact of the therapy with GLP-1 analogues (exenatide) toguether with basal insulin in glycemic control and weight of patients with type 2 diabetes mellitus poorly controlled.Materials and methods: We analyzed 37 patients with type 2 diabetes with poor glycemic control and obesity, treatment with exenatide and basal insulin. As pre-treatment 56.7% of our patients were with basal insulin, 10.8% with insulin mixtures and 32.4% with...